Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy

被引:110
作者
Erdmann, J
Raible, J
Maki-Abadi, J
Hummel, M
Hammann, J
Wollnik, B
Frantz, E
Fleck, E
Hetzer, R
Regitz-Zagrosek, V
机构
[1] Humboldt Univ, Campus Virchow Klinikum, Charite, Dept Internal Med, D-13353 Berlin, Germany
[2] Humboldt Univ, Campus Virchow Klinikum, Charite, Dept Cardiol, D-13353 Berlin, Germany
[3] Deutesch Herzzentrum, Berlin, Germany
[4] Univ Istanbul, Inst Child Hlth, Dept Med Genet, Istanbul, Turkey
关键词
D O I
10.1016/S0735-1097(01)01387-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives We studied the clinical and genetic features of hypertrophic cardiomyopathy (HCM) caused by mutations in the myosin-binding protein C gene (MYBPC3) in 110 consecutive, unrelated patients and family members of European descent. Background Mutations in the MYBPC3 gene represent the cause of HCM in similar to 15% of familial cases. MYBPC3 mutations were reported to include mainly nonsense versus missense mutations and to be characterized by a delayed onset and benign clinical course of the disease in Japanese and French families. We investigated the features that characterize MYBPC3 variants in a large, unrelated cohort of consecutive patients. Methods The MYBPC3 gene was screened by single-strand conformational polymorphism analysis and sequencing. The clinical phenotypes were analyzed using rest and 24-h electrocardiography, electrophysiology, two-dimensional and Doppler echocardiography and angiography. Results We identified 13 mutations in the: MYBPC3 gene: one nonsense, four missense and three splicing mutations and five small deletions and insertions. Of these, 11 were novel, and two were probably founder mutations. Patients with MYBPC3 mutations presented a broad range of phenotypes. In general the 16 carriers of protein truncations had a tendency toward earlier disease manifestations (33 +/- 13 vs. 48 +/-9 years; p = 0.06) and more frequently needed invasive procedures (septal ablation or cardioverter-defibrillator implantation) compared with the 9 carriers of missense mutations or in-frame deletions (12/16 vs. 1/9 patients; p < 0.01). Conclusions Multiple mutations, which include missense, nonsense and splicing mutations, as well as small deletions and insertions, occur in the MYBPC3 gene. Protein truncation mutations seem to cause a more severe disease phenotype than missense mutations or in-frame deletions. (J Am Coll Cardiol 2001;38:322-30) (C) 2001 by the American College of Cardiology.
引用
收藏
页码:322 / 330
页数:9
相关论文
共 31 条
  • [11] A MOLECULAR-BASIS FOR FAMILIAL HYPERTROPHIC CARDIOMYOPATHY - A BETA-CARDIAC MYOSIN HEAVY-CHAIN GENE MISSENSE MUTATION
    GEISTERFERLOWRANCE, AAT
    KASS, S
    TANIGAWA, G
    VOSBERG, HP
    MCKENNA, W
    SEIDMAN, CE
    SEIDMAN, JG
    [J]. CELL, 1990, 62 (05) : 999 - 1006
  • [12] Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart
    Gilbert, EM
    Abraham, WT
    Olsen, S
    Hattler, B
    White, M
    Mealy, P
    Larrabee, P
    Bristow, MR
    [J]. CIRCULATION, 1996, 94 (11) : 2817 - 2825
  • [13] Gilbert R, 1999, J CELL SCI, V112, P69
  • [14] Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy
    Kimura, A
    Harada, H
    Park, JE
    Nishi, H
    Satoh, M
    Takahashi, M
    Hiroi, S
    Sasaoka, T
    Ohbuchi, N
    Nakamura, T
    Koyanagi, T
    Hwang, TH
    Choo, TA
    Chung, KS
    Hasegawa, A
    Nagai, R
    Okazaki, O
    Nakamura, H
    Matsuzaki, M
    Sakamoto, T
    Toshima, H
    Koga, Y
    Imaizumi, T
    Sasazuki, T
    [J]. NATURE GENETICS, 1997, 16 (04) : 379 - 382
  • [15] ASSEMBLY OF CARDIAC C-PROTEIN DURING MYOFIBRILLOGENESIS IN MYOGENIC CELLS IN CULTURE
    KOSHIDA, S
    KURASAWA, M
    YASUDA, M
    SATO, N
    OBINATA, T
    [J]. CELL STRUCTURE AND FUNCTION, 1995, 20 (04) : 253 - 261
  • [16] RESULTS OF SCREENING A LARGE GROUP OF INTERCOLLEGIATE COMPETITIVE ATHLETES FOR CARDIOVASCULAR-DISEASE
    MARON, BJ
    BODISON, SA
    WESLEY, YE
    TUCKER, E
    GREEN, KJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 10 (06) : 1214 - 1221
  • [17] PREVALENCE OF HYPERTROPHIC CARDIOMYOPATHY IN A GENERAL-POPULATION OF YOUNG-ADULTS - ECHOCARDIOGRAPHIC ANALYSIS OF 4111 SUBJECTS IN THE CARDIA STUDY
    MARON, BJ
    GARDIN, JM
    FLACK, JM
    GIDDING, SS
    KUROSAKI, TT
    BILD, DE
    [J]. CIRCULATION, 1995, 92 (04) : 785 - 789
  • [18] α-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy
    Mogensen, J
    Klausen, IC
    Pedersen, AK
    Egeblad, H
    Bross, P
    Kruse, TA
    Gregersen, N
    Hansen, PS
    Baandrup, U
    Borglum, AD
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (10) : R39 - R43
  • [19] A newly created splice donor site in exon 25 of the MyBP-C gene is responsible for inherited hypertrophic cardiomyopathy with incomplete disease penetrance
    Moolman, JA
    Reith, S
    Uhl, K
    Bailey, S
    Gautel, M
    Jeschke, B
    Fischer, C
    Ochs, J
    McKenna, WJ
    Klues, H
    Vosberg, HP
    [J]. CIRCULATION, 2000, 101 (12) : 1396 - 1402
  • [20] Identification of a new missense mutation in MyBP-C associated with hypertrophic cardiomyopathy
    Moolman-Smook, JC
    Mayosi, B
    Brink, P
    Corfield, VA
    [J]. JOURNAL OF MEDICAL GENETICS, 1998, 35 (03) : 253 - 254